Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?
James H. Tabibian, Keith D. Lindor – 27 April 2016
Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1
I‐Fang Hsin, Erica Montano, Ekihiro Seki – 27 April 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans
Anastasia Asimakopoulos, Alessandra Mangia, Gregory J. Dore, Andrew R. Lloyd, Jacob George, Mohammed Eslam – 27 April 2016
The liver in systemic disease: Sepsis and critical illness
William Bernal – 27 April 2016
Transjugular intrahepatic portosystemic shunt for refractory ascites in patients with high model for end‐stage liver disease scores
Kavish R. Patidar, Arun J. Sanyal – 27 April 2016
Cryptogenic cirrhosis: Current knowledge and future directions
Alex Mercado‐Irizarry, Esther A. Torres – 27 April 2016
Reply
Guadalupe Garcia‐Tsao, Jordan Sack – 26 April 2016
Reply
Sudeep Banerjee, Michael D. Kuo – 26 April 2016
Statins in Cirrhosis: The Magic Pill?
Giuseppe Malizia, Gennaro D'Amico – 26 April 2016
Reply
Robert S. Brown, Brian J. McMahon, Anna S.F. Lok, John B. Wong, Ahmed T. Ahmed, Mohamad A. Mouchli, Zhen Wang, Larry J. Prokop, Mohammad Hassan Murad, Khaled Mohammed – 26 April 2016